Protagenic (PTIX) Exec Chair Armen Garo Buys 2,220 Shares

What Happened

• Armen Garo H, Executive Chair, Principal Officer and Director of Protagenic Therapeutics, purchased 2,220 shares of PTIX in an open-market transaction on 2026-08-11 at $0.32 per share, for a total of approximately $710. This was a direct purchase (transaction code P).

Key Details

• Transaction date and price: 2026-08-11 at $0.32 per share
• Shares acquired and value: 2,220 shares, ~ $710 total
• Transaction type: Open-market purchase (Code P)
• Filing date / timeliness: Form 4 filed 2026-08-12 (one day after the transaction) — appears timely
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnotes/plans: No 10b5-1 plan, tax withholding, or other footnotes were indicated in the summary provided

Context

• This was a small open-market purchase by an executive/insider. Purchases can be a useful data point for investors, but the small dollar amount here may also reflect routine buying rather than a major directional signal.